Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinlin Liu

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Journal of Hazardous Materials|February 26, 2013
Microwave-assisted in situ synthesis of reduced graphene oxide-BiVO4 composite photocatalysts and their enhanced photocatalytic performance for the degradation of ciprofloxacinYan Yan, Shaofang Sun, Yang Song, et al.
British Journal of Cancer|June 18, 2024
CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitorsXinlin Liu, Wei Li, Lu Yi, et al.
Frontiers in Immunology|November 24, 2025
Engineering HER2-targeted biparatopic antibodies to promote receptor internalization and restore antitumor efficacyXinlin Liu, Wanpeng Yu, Yihuan Wang, et al.
Nanoscale|October 27, 2022
van der Waals integration of mixed-dimensional CeO<sub>2</sub>@Bi heterostructure for high-performance self-powered photodetector with fast response speedXinlin Liu, Cailing Liu, Yushuang Fu, et al.
Foods (Basel, Switzerland)|January 10, 2026
Vanillin Activates HuTGA1-HuNPR1/5-1 Signaling to Enhance Postharvest Pitaya Resistance to Soft RotJian Xu, Xinlin Liu, Yilin He, et al.
Journal of Hematology & Oncology|July 6, 2026
Antibody-oligonucleotide conjugates: design principles, intracellular delivery, and translational opportunitiesYuqian Li, Xinlin Liu, Fuyuan Zhang, et al.
International Journal of Clinical and Experimental Pathology|June 14, 2022
Myocyte enhancer factor 2D promotes hepatocellular carcinoma through AMOTL2/YAP signaling that inhibited by luteolinQianqian Xu, Bing Gao, Xinlin Liu, et al.
International Immunopharmacology|May 17, 2026
Advanced platforms for antibody delivery: Overcoming biological barriers and improving therapeutic performanceYumeng Liu, Qi Li, Wanpeng Yu, et al.
Oncogene|October 24, 2024
PTPRZ1 dephosphorylates and stabilizes RNF26 to reduce the efficacy of TKIs and PD-1 blockade in ccRCCYongkang Ma, Wei Li, Xinlin Liu, et al.
Journal of Pharmaceutical Analysis|August 30, 2024
miR-135b: An emerging player in cardio-cerebrovascular diseasesYingchun Shao, Jiazhen Xu, Wujun Chen, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Journal of Hazardous Materials|February 26, 2013
Microwave-assisted in situ synthesis of reduced graphene oxide-BiVO4 composite photocatalysts and their enhanced photocatalytic performance for the degradation of ciprofloxacinYan Yan, Shaofang Sun, Yang Song, et al.
British Journal of Cancer|June 18, 2024
CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitorsXinlin Liu, Wei Li, Lu Yi, et al.
Frontiers in Immunology|November 24, 2025
Engineering HER2-targeted biparatopic antibodies to promote receptor internalization and restore antitumor efficacyXinlin Liu, Wanpeng Yu, Yihuan Wang, et al.
Nanoscale|October 27, 2022
van der Waals integration of mixed-dimensional CeO<sub>2</sub>@Bi heterostructure for high-performance self-powered photodetector with fast response speedXinlin Liu, Cailing Liu, Yushuang Fu, et al.
Foods (Basel, Switzerland)|January 10, 2026
Vanillin Activates HuTGA1-HuNPR1/5-1 Signaling to Enhance Postharvest Pitaya Resistance to Soft RotJian Xu, Xinlin Liu, Yilin He, et al.
Journal of Hematology & Oncology|July 6, 2026
Antibody-oligonucleotide conjugates: design principles, intracellular delivery, and translational opportunitiesYuqian Li, Xinlin Liu, Fuyuan Zhang, et al.
International Journal of Clinical and Experimental Pathology|June 14, 2022
Myocyte enhancer factor 2D promotes hepatocellular carcinoma through AMOTL2/YAP signaling that inhibited by luteolinQianqian Xu, Bing Gao, Xinlin Liu, et al.
International Immunopharmacology|May 17, 2026
Advanced platforms for antibody delivery: Overcoming biological barriers and improving therapeutic performanceYumeng Liu, Qi Li, Wanpeng Yu, et al.
Oncogene|October 24, 2024
PTPRZ1 dephosphorylates and stabilizes RNF26 to reduce the efficacy of TKIs and PD-1 blockade in ccRCCYongkang Ma, Wei Li, Xinlin Liu, et al.
Journal of Pharmaceutical Analysis|August 30, 2024
miR-135b: An emerging player in cardio-cerebrovascular diseasesYingchun Shao, Jiazhen Xu, Wujun Chen, et al.
Pageof 9